SCHEMBL24590073

SCHEMBL24590073

CCN(CC)c1ccc2c(C)c(CCNC(=O)OC(C)(C)C)c(=O)oc2c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IGLV6-57 P01721 10/20 0.61
▸ KDM4E B2RXH2 6/20 0.60
▸ ALDH1A1 P00352 6/20 0.60
▸ GLA P06280 4/20 0.60
▸ ATM Q13315 3/20 0.60
▸ GAA P10253 3/20 0.60
▸ KLK7 P49862 1/20 0.60
▸ HTT P42858 3/20 0.59
▸ CASP1 P29466 3/20 0.59
▸ CASP7 P55210 3/20 0.59
▸ HSD17B10 Q99714 3/20 0.59
▸ MAPT P10636 2/20 0.59
▸ L3MBTL1 Q9Y468 2/20 0.59
▸ LMNA P02545 1/20 0.59
▸ THRB P10828 1/20 0.59
▸ SRC P12931 2/20 0.53
▸ HPGD P15428 3/20 0.52
▸ MEN1 O00255 1/20 0.52
▸ KMT2A Q03164 1/20 0.52
▸ TDP1 Q9NUW8 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22501670 0.90 IGLV6-57 (0.65) IGLV6-57KDM4EALDH1A1GLAATM
SCHEMBL22501642 0.87 KDM4E (0.69) IGLV6-57KDM4EALDH1A1GLAATM
SCHEMBL24590109 0.86 ALDH1A1 (0.67) IGLV6-57KDM4EALDH1A1GLAATM
SCHEMBL24590329 0.85 KDM4E (0.66) IGLV6-57KDM4EALDH1A1GLAATM
SCHEMBL22501629 0.84 ALDH1A1 (0.65) IGLV6-57KDM4EALDH1A1GLAATM
SCHEMBL4922302 0.81 ALDH1A1 (0.51) IGLV6-57KDM4EALDH1A1GLAATM
SCHEMBL24590076 0.81 IGLV6-57 (0.85) IGLV6-57KDM4EALDH1A1GLAATM
SCHEMBL24590074 0.80 KDM4E (0.59) IGLV6-57KDM4EALDH1A1GLAATM
SCHEMBL24589806 0.79 IGLV6-57 (0.82) IGLV6-57KDM4EALDH1A1GLAATM
SCHEMBL24589957 0.79 IGLV6-57 (0.74) IGLV6-57KDM4EALDH1A1GLAATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11945806-B2 Stabilization of amyloidogenic immunoglobulin light chains THE SCRIPPS RESEARCH INSTITUTE 2024-04-02 — — US disclosed
US-20220204485-A1 STABILIZATION OF AMYLOIDOGENIC IMMUNOGLOBULIN LIGHT CHAINS THE SCRIPPS RESEARCH INSTITUTE 2022-06-30 — — US disclosed
US-20220204485-A1 STABILIZATION OF AMYLOIDOGENIC IMMUNOGLOBULIN LIGHT CHAINS THE SCRIPPS RESEARCH INSTITUTE 2022-06-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220204485-A1 STABILIZATION OF AMYLOIDOGENIC IMMUNOGLOBULIN LIGHT CHAINS TTR, MAP1LC3B, SAAL1 IGLV6-57 7/4885KDM4E 4575/4885ALDH1A1 2072/4885
US-11945806-B2 Stabilization of amyloidogenic immunoglobulin light chains TTR, MAP1LC3B, SAAL1 IGLV6-57 7/4885KDM4E 4575/4885ALDH1A1 2072/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback